NABUMETONE

Generic: NABUMETONE

ANI PharmaceuticalsManufacturer
ORALRoute
NABUMETONEActive Substance
2025-01-07Original Approval

NABUMETONE is FDA application ANDA219118, sponsored by NOVITIUM PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DRUG INEFFECTIVE
507 reports
2
PAIN
465 reports
3
NAUSEA
375 reports
4
FATIGUE
362 reports
5
HEADACHE
320 reports
6
ARTHRALGIA
311 reports
7
DYSPNOEA
245 reports
8
DIARRHOEA
241 reports
9
PAIN IN EXTREMITY
226 reports
10
DIZZINESS
225 reports